HOME › DRUGS › ANAKINRA
ACTIVE SUBSTANCE / INN

ANAKINRA

Brand name(s): Kineret, KINERET
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA103950
Arthritis, Rheumatoid;COVID-19 virus infection
ACTIVE SUBSTANCE
Anakinra
REGULATORS
FDA · EMA
SPONSORS / MAH
Swedish Orphan Biovitrum AB (publ), BIOVITRUM AB
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KINERETBLA103950BIOVITRUM ABPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KineretSwedish Orphan Biovitrum AB (publ)Authorised08/03/2002Arthritis, Rheumatoid;COVID-19 virus infection

FULL INTELLIGENCE ON ANAKINRA

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →